Hallie Kuhn, Ph.D.

Hallie Kuhn, Ph.D.

Vice President – Science & Technology, Alexandria Real Estate Equities, Inc. / Alexandria Venture Investments

Hallie Kuhn, PhD, is Vice President – Science & Technology at Alexandria Real Estate Equities, Inc., an S&P 500® urban office REIT (Alexandria), and Alexandria Venture Investments, the company’s strategic venture capital platform. In her role, Dr. Kuhn oversees venture investments, tenant underwriting, and business development in Alexandria’s San Diego and Greater Los Angeles clusters. Through Alexandria Venture Investments, Dr. Kuhn has led and manages more than 25 early- and growth-stage Southern California life science investments spanning therapeutics, research tools, and molecular diagnostics. Alexandria Venture Investments has been recognized by Silicon Valley Bank as the most active biopharma corporate investor by new deal volume for the last four consecutive years.

Formerly, Dr. Kuhn was a Principal at LS Polaris Innovation Fund, a Boston-based VC fund specializing in early-stage life science investments. She concurrently served as Chief of Staff for Polaris Partner Amy Schulman, supporting business development and operations for multiple companies, including Olivo Laboratories (acquired by Shiseido) and Lyndra Therapeutics. Prior to Polaris, she was a Senior Consultant at Clearview Healthcare Partners, where she engaged biopharma companies on strategic projects covering the full cycle of drug development and commercialization. Dr. Kuhn holds a PhD in Systems Biology from Harvard University and was a Churchill Scholar at Cambridge University. She is a recipient of a National Science Foundation Graduate Fellowship, National Defense Science and Engineering Fellowship, and Harvard Ashford Fellowship. She holds a BS from Harvey Mudd College.